Prevention and treatment of bone infection with CSA-90 [ 2016 - 2018 ]

Research Grant

Researchers: Prof David Little (Principal investigator) ,  A/Pr Aaron Schindeler ,  Prof David Isaacs

Brief description Bone infections are a major challenge to treat, especially with the rise of drug resistant “superbugs”. We have access to a new agent, CSA-90, that has dual properties of being anti-microbial (antibiotic) and helps encourage bone growth. This project aims to expand upon our prior research and test CSA-90 for the treatment of chronic bone infections. We will also look at applying this technology to joint replacements and this drug may be particularly useful for coating orthopaedic implants.

Funding Amount $AUD 360,546.00

Funding Scheme Project Grants

Notes Standard Project Grant